JP2005511543A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005511543A5 JP2005511543A5 JP2003537644A JP2003537644A JP2005511543A5 JP 2005511543 A5 JP2005511543 A5 JP 2005511543A5 JP 2003537644 A JP2003537644 A JP 2003537644A JP 2003537644 A JP2003537644 A JP 2003537644A JP 2005511543 A5 JP2005511543 A5 JP 2005511543A5
- Authority
- JP
- Japan
- Prior art keywords
- oxo
- methyl
- hydroxy
- alkyl
- carboxamide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000000217 alkyl group Chemical group 0.000 claims 123
- 125000001424 substituent group Chemical group 0.000 claims 76
- -1 —OH Chemical group 0.000 claims 35
- 229910052736 halogen Inorganic materials 0.000 claims 33
- 150000002367 halogens Chemical group 0.000 claims 32
- 125000005842 heteroatom Chemical group 0.000 claims 29
- 229910052760 oxygen Inorganic materials 0.000 claims 28
- 229910052717 sulfur Inorganic materials 0.000 claims 28
- 125000003118 aryl group Chemical group 0.000 claims 27
- 125000000623 heterocyclic group Chemical group 0.000 claims 25
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 20
- 125000001072 heteroaryl group Chemical group 0.000 claims 19
- 150000001875 compounds Chemical class 0.000 claims 18
- 125000004043 oxo group Chemical group O=* 0.000 claims 17
- 125000004176 4-fluorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1F)C([H])([H])* 0.000 claims 13
- 150000003839 salts Chemical class 0.000 claims 12
- 125000002618 bicyclic heterocycle group Chemical group 0.000 claims 11
- 229920006395 saturated elastomer Polymers 0.000 claims 9
- 150000003857 carboxamides Chemical class 0.000 claims 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 6
- 125000002877 alkyl aryl group Chemical group 0.000 claims 5
- 125000002619 bicyclic group Chemical group 0.000 claims 5
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims 4
- 125000004485 2-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])C1([H])* 0.000 claims 4
- 125000004432 carbon atom Chemical group C* 0.000 claims 4
- 125000001188 haloalkyl group Chemical group 0.000 claims 4
- 125000002950 monocyclic group Chemical group 0.000 claims 4
- 125000002837 carbocyclic group Chemical group 0.000 claims 3
- 125000000753 cycloalkyl group Chemical group 0.000 claims 3
- MMPZNODECHHWIW-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-2-(4-methylmorpholin-3-yl)-6-oxopyrimidine-4-carboxamide Chemical compound CN1CCOCC1C1=NC(C(=O)NCC=2C=CC(F)=CC=2)=C(O)C(=O)N1C MMPZNODECHHWIW-UHFFFAOYSA-N 0.000 claims 3
- 125000001624 naphthyl group Chemical group 0.000 claims 3
- 229910052757 nitrogen Inorganic materials 0.000 claims 3
- 125000006705 (C5-C7) cycloalkyl group Chemical group 0.000 claims 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 2
- 125000004122 cyclic group Chemical group 0.000 claims 2
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 125000003709 fluoroalkyl group Chemical group 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- CZFFBEXEKNGXKS-UHFFFAOYSA-N raltegravir Chemical compound O1C(C)=NN=C1C(=O)NC(C)(C)C1=NC(C(=O)NCC=2C=CC(F)=CC=2)=C(O)C(=O)N1C CZFFBEXEKNGXKS-UHFFFAOYSA-N 0.000 claims 2
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 claims 1
- HALJILNZFAWGDL-UHFFFAOYSA-N 1-[2-(dimethylamino)ethyl]-n-[(4-fluorophenyl)methyl]-5-hydroxy-2-(2-methylphenyl)-6-oxopyrimidine-4-carboxamide Chemical compound OC=1C(=O)N(CCN(C)C)C(C=2C(=CC=CC=2)C)=NC=1C(=O)NCC1=CC=C(F)C=C1 HALJILNZFAWGDL-UHFFFAOYSA-N 0.000 claims 1
- INUPCGQJKUVPAZ-UHFFFAOYSA-N 1-[2-(dimethylamino)ethyl]-n-[(4-fluorophenyl)methyl]-5-hydroxy-6-oxopyrimidine-4-carboxamide Chemical compound O=C1N(CCN(C)C)C=NC(C(=O)NCC=2C=CC(F)=CC=2)=C1O INUPCGQJKUVPAZ-UHFFFAOYSA-N 0.000 claims 1
- HBODMPJFESBLQE-UHFFFAOYSA-N 1-[[3-[(dimethylamino)methyl]phenyl]methyl]-n-[(4-fluorophenyl)methyl]-5-hydroxy-6-oxopyrimidine-4-carboxamide Chemical compound CN(C)CC1=CC=CC(CN2C(C(O)=C(C(=O)NCC=3C=CC(F)=CC=3)N=C2)=O)=C1 HBODMPJFESBLQE-UHFFFAOYSA-N 0.000 claims 1
- ZUEYJJHLMMKJSS-UHFFFAOYSA-N 2-(1,2-dimethyl-4-methylsulfonylpiperazin-2-yl)-n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound CN1CCN(S(C)(=O)=O)CC1(C)C1=NC(C(=O)NCC=2C=CC(F)=CC=2)=C(O)C(=O)N1C ZUEYJJHLMMKJSS-UHFFFAOYSA-N 0.000 claims 1
- HTUOQGFZWIWCSK-UHFFFAOYSA-N 2-(1,4-dimethylpiperazin-2-yl)-n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound C1N(C)CCN(C)C1C1=NC(C(=O)NCC=2C=CC(F)=CC=2)=C(O)C(=O)N1C HTUOQGFZWIWCSK-UHFFFAOYSA-N 0.000 claims 1
- ZWZSSLLTACAMTK-UHFFFAOYSA-N 2-(1-acetylpyrrolidin-2-yl)-5-hydroxy-1-methyl-n-[(2-methylsulfanylphenyl)methyl]-6-oxopyrimidine-4-carboxamide Chemical compound CSC1=CC=CC=C1CNC(=O)C1=C(O)C(=O)N(C)C(C2N(CCC2)C(C)=O)=N1 ZWZSSLLTACAMTK-UHFFFAOYSA-N 0.000 claims 1
- NMUQSBDHGNXUKW-UHFFFAOYSA-N 2-(1-acetylpyrrolidin-2-yl)-5-hydroxy-n-[(2-methoxyphenyl)methyl]-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound COC1=CC=CC=C1CNC(=O)C1=C(O)C(=O)N(C)C(C2N(CCC2)C(C)=O)=N1 NMUQSBDHGNXUKW-UHFFFAOYSA-N 0.000 claims 1
- UNWSVMJDBKFGES-UHFFFAOYSA-N 2-(1-acetylpyrrolidin-2-yl)-n-[(2,3-dimethoxyphenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound COC1=CC=CC(CNC(=O)C2=C(C(=O)N(C)C(C3N(CCC3)C(C)=O)=N2)O)=C1OC UNWSVMJDBKFGES-UHFFFAOYSA-N 0.000 claims 1
- AIIQXBVWKSDGKV-UHFFFAOYSA-N 2-(1-acetylpyrrolidin-2-yl)-n-[(2-ethoxyphenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound CCOC1=CC=CC=C1CNC(=O)C1=C(O)C(=O)N(C)C(C2N(CCC2)C(C)=O)=N1 AIIQXBVWKSDGKV-UHFFFAOYSA-N 0.000 claims 1
- BWOYEQBLDGFHHV-UHFFFAOYSA-N 2-(1-acetylpyrrolidin-2-yl)-n-[(4-fluoro-2-methylsulfonylphenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound CC(=O)N1CCCC1C1=NC(C(=O)NCC=2C(=CC(F)=CC=2)S(C)(=O)=O)=C(O)C(=O)N1C BWOYEQBLDGFHHV-UHFFFAOYSA-N 0.000 claims 1
- SXBRRPCHWCRBGM-UHFFFAOYSA-N 2-(1-acetylpyrrolidin-2-yl)-n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound CC(=O)N1CCCC1C1=NC(C(=O)NCC=2C=CC(F)=CC=2)=C(O)C(=O)N1C SXBRRPCHWCRBGM-UHFFFAOYSA-N 0.000 claims 1
- FHAGWXHXFUVYQQ-UHFFFAOYSA-N 2-(1-acetylpyrrolidin-2-yl)-n-[[2-(dimethylamino)phenyl]methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound CN(C)C1=CC=CC=C1CNC(=O)C1=C(O)C(=O)N(C)C(C2N(CCC2)C(C)=O)=N1 FHAGWXHXFUVYQQ-UHFFFAOYSA-N 0.000 claims 1
- GVTUUPQFRYGXMA-UHFFFAOYSA-N 2-(1-benzoyl-2,3-dihydroindol-2-yl)-n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound OC=1C(=O)N(C)C(C2N(C3=CC=CC=C3C2)C(=O)C=2C=CC=CC=2)=NC=1C(=O)NCC1=CC=C(F)C=C1 GVTUUPQFRYGXMA-UHFFFAOYSA-N 0.000 claims 1
- OIDDKWLJNSSGGV-UHFFFAOYSA-N 2-(1-benzoyl-4-methylpiperazin-2-yl)-n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound C1N(C)CCN(C(=O)C=2C=CC=CC=2)C1C(N(C(=O)C=1O)C)=NC=1C(=O)NCC1=CC=C(F)C=C1 OIDDKWLJNSSGGV-UHFFFAOYSA-N 0.000 claims 1
- UYIXIEHDYTWNJZ-UHFFFAOYSA-N 2-(1-benzoylpiperidin-2-yl)-n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound OC=1C(=O)N(C)C(C2N(CCCC2)C(=O)C=2C=CC=CC=2)=NC=1C(=O)NCC1=CC=C(F)C=C1 UYIXIEHDYTWNJZ-UHFFFAOYSA-N 0.000 claims 1
- QRIHGCAEXUHLOW-UHFFFAOYSA-N 2-(1-benzoylpyrrolidin-2-yl)-n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound OC=1C(=O)N(C)C(C2N(CCC2)C(=O)C=2C=CC=CC=2)=NC=1C(=O)NCC1=CC=C(F)C=C1 QRIHGCAEXUHLOW-UHFFFAOYSA-N 0.000 claims 1
- NIRJXSNAERBOTN-UHFFFAOYSA-N 2-(1-benzylpiperidin-2-yl)-n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound OC=1C(=O)N(C)C(C2N(CCCC2)CC=2C=CC=CC=2)=NC=1C(=O)NCC1=CC=C(F)C=C1 NIRJXSNAERBOTN-UHFFFAOYSA-N 0.000 claims 1
- RPTNZNNUJDCPCA-UHFFFAOYSA-N 2-(1-benzylpiperidin-3-yl)-n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound OC=1C(=O)N(C)C(C2CN(CC=3C=CC=CC=3)CCC2)=NC=1C(=O)NCC1=CC=C(F)C=C1 RPTNZNNUJDCPCA-UHFFFAOYSA-N 0.000 claims 1
- RNIPBSWCXDEYGJ-UHFFFAOYSA-N 2-(1-ethyl-2,3-dihydroindol-2-yl)-n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound C1C2=CC=CC=C2N(CC)C1C(N(C(=O)C=1O)C)=NC=1C(=O)NCC1=CC=C(F)C=C1 RNIPBSWCXDEYGJ-UHFFFAOYSA-N 0.000 claims 1
- DSYZHJDLBCRDPT-UHFFFAOYSA-N 2-(2,2-dimethoxyethyl)-n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound O=C1N(C)C(CC(OC)OC)=NC(C(=O)NCC=2C=CC(F)=CC=2)=C1O DSYZHJDLBCRDPT-UHFFFAOYSA-N 0.000 claims 1
- RSNBQZPGNYQALO-UHFFFAOYSA-N 2-(2,3-dihydro-1h-indol-2-yl)-n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound OC=1C(=O)N(C)C(C2NC3=CC=CC=C3C2)=NC=1C(=O)NCC1=CC=C(F)C=C1 RSNBQZPGNYQALO-UHFFFAOYSA-N 0.000 claims 1
- FGCQVGQJXOFNDP-UHFFFAOYSA-N 2-(2-acetamidopropan-2-yl)-n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound O=C1N(C)C(C(C)(C)NC(=O)C)=NC(C(=O)NCC=2C=CC(F)=CC=2)=C1O FGCQVGQJXOFNDP-UHFFFAOYSA-N 0.000 claims 1
- VENKFOMMRMCXSN-UHFFFAOYSA-N 2-(3-acetyl-1,3-thiazolidin-2-yl)-n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound CC(=O)N1CCSC1C1=NC(C(=O)NCC=2C=CC(F)=CC=2)=C(O)C(=O)N1C VENKFOMMRMCXSN-UHFFFAOYSA-N 0.000 claims 1
- DYGQWEZNJAWTMH-UHFFFAOYSA-N 2-(4-acetyl-1-methylpiperazin-2-yl)-n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound CN1CCN(C(C)=O)CC1C1=NC(C(=O)NCC=2C=CC(F)=CC=2)=C(O)C(=O)N1C DYGQWEZNJAWTMH-UHFFFAOYSA-N 0.000 claims 1
- BMTUWFRODUAELZ-UHFFFAOYSA-N 2-(4-benzoyl-1-methylpiperazin-2-yl)-n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound CN1CCN(C(=O)C=2C=CC=CC=2)CC1C(N(C(=O)C=1O)C)=NC=1C(=O)NCC1=CC=C(F)C=C1 BMTUWFRODUAELZ-UHFFFAOYSA-N 0.000 claims 1
- KICKGPQKASOONE-UHFFFAOYSA-N 2-(4-ethyl-1-methylpiperazin-2-yl)-n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound C1N(CC)CCN(C)C1C1=NC(C(=O)NCC=2C=CC(F)=CC=2)=C(O)C(=O)N1C KICKGPQKASOONE-UHFFFAOYSA-N 0.000 claims 1
- DWVBVURKCZQKOS-HUUCEWRRSA-N 2-[(2r,4r)-1-[2-(dimethylamino)-2-oxoacetyl]-4-methoxypyrrolidin-2-yl]-n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound CN(C)C(=O)C(=O)N1C[C@H](OC)C[C@@H]1C1=NC(C(=O)NCC=2C=CC(F)=CC=2)=C(O)C(=O)N1C DWVBVURKCZQKOS-HUUCEWRRSA-N 0.000 claims 1
- VWXCOJBXZNKXDR-HZPDHXFCSA-N 2-[(2r,4r)-1-acetyl-4-ethoxypyrrolidin-2-yl]-n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound CC(=O)N1C[C@H](OCC)C[C@@H]1C1=NC(C(=O)NCC=2C=CC(F)=CC=2)=C(O)C(=O)N1C VWXCOJBXZNKXDR-HZPDHXFCSA-N 0.000 claims 1
- WKDOSXUSFIHGPZ-HUUCEWRRSA-N 2-[(2r,4r)-1-acetyl-4-methoxypyrrolidin-2-yl]-n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound CC(=O)N1C[C@H](OC)C[C@@H]1C1=NC(C(=O)NCC=2C=CC(F)=CC=2)=C(O)C(=O)N1C WKDOSXUSFIHGPZ-HUUCEWRRSA-N 0.000 claims 1
- KQGKCKYQHCMVBU-RTBURBONSA-N 2-[(2r,4r)-1-benzoyl-4-methoxypyrrolidin-2-yl]-n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound N1([C@H](C[C@H](C1)OC)C=1N(C(=O)C(O)=C(C(=O)NCC=2C=CC(F)=CC=2)N=1)C)C(=O)C1=CC=CC=C1 KQGKCKYQHCMVBU-RTBURBONSA-N 0.000 claims 1
- GUPLVGUUZBBMSC-HUUCEWRRSA-N 2-[(2r,4r)-4-ethoxy-1-[2-(methylamino)-2-oxoacetyl]pyrrolidin-2-yl]-n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound CNC(=O)C(=O)N1C[C@H](OCC)C[C@@H]1C1=NC(C(=O)NCC=2C=CC(F)=CC=2)=C(O)C(=O)N1C GUPLVGUUZBBMSC-HUUCEWRRSA-N 0.000 claims 1
- IZAMFVNHGWAIIH-AWEZNQCLSA-N 2-[(2s)-1-[2-(dimethylamino)-2-oxoacetyl]pyrrolidin-2-yl]-n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound CN(C)C(=O)C(=O)N1CCC[C@H]1C1=NC(C(=O)NCC=2C=CC(F)=CC=2)=C(O)C(=O)N1C IZAMFVNHGWAIIH-AWEZNQCLSA-N 0.000 claims 1
- JJMZDFZRSSKHCW-ZDUSSCGKSA-N 2-[(2s)-1-acetyl-4,4-difluoropyrrolidin-2-yl]-n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound CC(=O)N1CC(F)(F)C[C@H]1C1=NC(C(=O)NCC=2C=CC(F)=CC=2)=C(O)C(=O)N1C JJMZDFZRSSKHCW-ZDUSSCGKSA-N 0.000 claims 1
- SXBRRPCHWCRBGM-AWEZNQCLSA-N 2-[(2s)-1-acetylpyrrolidin-2-yl]-n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound CC(=O)N1CCC[C@H]1C1=NC(C(=O)NCC=2C=CC(F)=CC=2)=C(O)C(=O)N1C SXBRRPCHWCRBGM-AWEZNQCLSA-N 0.000 claims 1
- VBNMBVHOVXGRIT-HNNXBMFYSA-N 2-[(2s)-4,4-difluoro-1-(pyrazine-2-carbonyl)pyrrolidin-2-yl]-n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound OC=1C(=O)N(C)C([C@H]2N(CC(F)(F)C2)C(=O)C=2N=CC=NC=2)=NC=1C(=O)NCC1=CC=C(F)C=C1 VBNMBVHOVXGRIT-HNNXBMFYSA-N 0.000 claims 1
- OLQXVJVOJZSEHE-HNNXBMFYSA-N 2-[(2s)-4,4-difluoro-1-(pyridazine-3-carbonyl)pyrrolidin-2-yl]-n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound OC=1C(=O)N(C)C([C@H]2N(CC(F)(F)C2)C(=O)C=2N=NC=CC=2)=NC=1C(=O)NCC1=CC=C(F)C=C1 OLQXVJVOJZSEHE-HNNXBMFYSA-N 0.000 claims 1
- VXMCFIODWHQIEV-INIZCTEOSA-N 2-[(2s)-4,4-difluoro-1-(pyridine-2-carbonyl)pyrrolidin-2-yl]-n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound OC=1C(=O)N(C)C([C@H]2N(CC(F)(F)C2)C(=O)C=2N=CC=CC=2)=NC=1C(=O)NCC1=CC=C(F)C=C1 VXMCFIODWHQIEV-INIZCTEOSA-N 0.000 claims 1
- RSZZZMBAKCZCMS-LBPRGKRZSA-N 2-[(2s)-4,4-difluoro-1-methylpyrrolidin-2-yl]-n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound CN1CC(F)(F)C[C@H]1C1=NC(C(=O)NCC=2C=CC(F)=CC=2)=C(O)C(=O)N1C RSZZZMBAKCZCMS-LBPRGKRZSA-N 0.000 claims 1
- WGVOGOWLJMYYJM-KGLIPLIRSA-N 2-[(2s,4r)-1-acetyl-4-hydroxypyrrolidin-2-yl]-n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound CC(=O)N1C[C@H](O)C[C@H]1C1=NC(C(=O)NCC=2C=CC(F)=CC=2)=C(O)C(=O)N1C WGVOGOWLJMYYJM-KGLIPLIRSA-N 0.000 claims 1
- FOSNNBJCOZOKQS-RTWAWAEBSA-N 2-[(2s,4r)-1-acetyl-4-phenylmethoxypyrrolidin-2-yl]-n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound OC=1C(=O)N(C)C([C@@H]2C[C@H](CN2C(=O)C)OCC=2C=CC=CC=2)=NC=1C(=O)NCC1=CC=C(F)C=C1 FOSNNBJCOZOKQS-RTWAWAEBSA-N 0.000 claims 1
- XWCKLKLAVPVPPD-MSOLQXFVSA-N 2-[(2s,4r)-1-benzoyl-4-hydroxypyrrolidin-2-yl]-n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound OC=1C(=O)N(C)C([C@H]2N(C[C@H](O)C2)C(=O)C=2C=CC=CC=2)=NC=1C(=O)NCC1=CC=C(F)C=C1 XWCKLKLAVPVPPD-MSOLQXFVSA-N 0.000 claims 1
- MMUHCXFDVPIMLD-RPBOFIJWSA-N 2-[(2s,4r)-1-benzoyl-4-phenylmethoxypyrrolidin-2-yl]-n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound OC=1C(=O)N(C)C([C@H]2N(C[C@@H](C2)OCC=2C=CC=CC=2)C(=O)C=2C=CC=CC=2)=NC=1C(=O)NCC1=CC=C(F)C=C1 MMUHCXFDVPIMLD-RPBOFIJWSA-N 0.000 claims 1
- WBMNCNFOEYRXFC-KBPBESRZSA-N 2-[(2s,4s)-1-[2-(dimethylamino)-2-oxoacetyl]-4-fluoropyrrolidin-2-yl]-n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound CN(C)C(=O)C(=O)N1C[C@@H](F)C[C@H]1C1=NC(C(=O)NCC=2C=CC(F)=CC=2)=C(O)C(=O)N1C WBMNCNFOEYRXFC-KBPBESRZSA-N 0.000 claims 1
- NBBLWTOHJFZTMU-KBPBESRZSA-N 2-[(2s,4s)-1-acetyl-4-fluoropyrrolidin-2-yl]-n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound CC(=O)N1C[C@@H](F)C[C@H]1C1=NC(C(=O)NCC=2C=CC(F)=CC=2)=C(O)C(=O)N1C NBBLWTOHJFZTMU-KBPBESRZSA-N 0.000 claims 1
- MBSMKNIEBKYDJI-STQMWFEESA-N 2-[(2s,4s)-4-fluoro-1-methylpyrrolidin-2-yl]-n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound CN1C[C@@H](F)C[C@H]1C1=NC(C(=O)NCC=2C=CC(F)=CC=2)=C(O)C(=O)N1C MBSMKNIEBKYDJI-STQMWFEESA-N 0.000 claims 1
- IRJHHBQBOGTQHA-UHFFFAOYSA-N 2-[1-(6-bromopyridine-2-carbonyl)pyrrolidin-2-yl]-n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound OC=1C(=O)N(C)C(C2N(CCC2)C(=O)C=2N=C(Br)C=CC=2)=NC=1C(=O)NCC1=CC=C(F)C=C1 IRJHHBQBOGTQHA-UHFFFAOYSA-N 0.000 claims 1
- SEMGKLXXSSDYCD-UHFFFAOYSA-N 2-[1-(cyclopropanecarbonyl)pyrrolidin-2-yl]-n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound OC=1C(=O)N(C)C(C2N(CCC2)C(=O)C2CC2)=NC=1C(=O)NCC1=CC=C(F)C=C1 SEMGKLXXSSDYCD-UHFFFAOYSA-N 0.000 claims 1
- NGPNFONVUNXVEL-UHFFFAOYSA-N 2-[1-(dimethylamino)-2-phenylethyl]-n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound N=1C(C(=O)NCC=2C=CC(F)=CC=2)=C(O)C(=O)N(C)C=1C(N(C)C)CC1=CC=CC=C1 NGPNFONVUNXVEL-UHFFFAOYSA-N 0.000 claims 1
- LPAJVYWERLVLOW-UHFFFAOYSA-N 2-[1-(dimethylsulfamoyl)pyrrolidin-2-yl]-n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound CN(C)S(=O)(=O)N1CCCC1C1=NC(C(=O)NCC=2C=CC(F)=CC=2)=C(O)C(=O)N1C LPAJVYWERLVLOW-UHFFFAOYSA-N 0.000 claims 1
- RFJKJXDRFILWJW-UHFFFAOYSA-N 2-[1-(ethylcarbamoyl)pyrrolidin-2-yl]-n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound CCNC(=O)N1CCCC1C1=NC(C(=O)NCC=2C=CC(F)=CC=2)=C(O)C(=O)N1C RFJKJXDRFILWJW-UHFFFAOYSA-N 0.000 claims 1
- IZAMFVNHGWAIIH-UHFFFAOYSA-N 2-[1-[2-(dimethylamino)-2-oxoacetyl]pyrrolidin-2-yl]-n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound CN(C)C(=O)C(=O)N1CCCC1C1=NC(C(=O)NCC=2C=CC(F)=CC=2)=C(O)C(=O)N1C IZAMFVNHGWAIIH-UHFFFAOYSA-N 0.000 claims 1
- YOHRQCNYRAVGRT-UHFFFAOYSA-N 2-[1-[2-(dimethylamino)acetyl]-2,3-dihydroindol-2-yl]-n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound C1C2=CC=CC=C2N(C(=O)CN(C)C)C1C(N(C(=O)C=1O)C)=NC=1C(=O)NCC1=CC=C(F)C=C1 YOHRQCNYRAVGRT-UHFFFAOYSA-N 0.000 claims 1
- UTJPUNPSZAIQOP-UHFFFAOYSA-N 2-[2-(4-benzoylpiperazin-1-yl)ethyl]-n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound N=1C(C(=O)NCC=2C=CC(F)=CC=2)=C(O)C(=O)N(C)C=1CCN(CC1)CCN1C(=O)C1=CC=CC=C1 UTJPUNPSZAIQOP-UHFFFAOYSA-N 0.000 claims 1
- QBEHHCHEEFSDBW-UHFFFAOYSA-N 2-[4-(diethylaminomethyl)phenyl]-n-[(2,3-dimethoxyphenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound C1=CC(CN(CC)CC)=CC=C1C1=NC(C(=O)NCC=2C(=C(OC)C=CC=2)OC)=C(O)C(=O)N1C QBEHHCHEEFSDBW-UHFFFAOYSA-N 0.000 claims 1
- TTYMRCQTUGHFEE-UHFFFAOYSA-N 2-[4-(diethylaminomethyl)phenyl]-n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound C1=CC(CN(CC)CC)=CC=C1C1=NC(C(=O)NCC=2C=CC(F)=CC=2)=C(O)C(=O)N1C TTYMRCQTUGHFEE-UHFFFAOYSA-N 0.000 claims 1
- LOEDFWHPBPEHLI-UHFFFAOYSA-N 2-[4-[(dimethylamino)methyl]phenyl]-n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound C1=CC(CN(C)C)=CC=C1C1=NC(C(=O)NCC=2C=CC(F)=CC=2)=C(O)C(=O)N1C LOEDFWHPBPEHLI-UHFFFAOYSA-N 0.000 claims 1
- KNIHLZWBFJLOPD-UHFFFAOYSA-N 2-[dimethylamino(phenyl)methyl]-n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound N=1C(C(=O)NCC=2C=CC(F)=CC=2)=C(O)C(=O)N(C)C=1C(N(C)C)C1=CC=CC=C1 KNIHLZWBFJLOPD-UHFFFAOYSA-N 0.000 claims 1
- XTMHZHQBCWWIIM-UHFFFAOYSA-N 2-benzyl-1-[2-(dimethylamino)ethyl]-n-[(4-fluorophenyl)methyl]-5-hydroxy-6-oxopyrimidine-4-carboxamide Chemical compound N=1C(C(=O)NCC=2C=CC(F)=CC=2)=C(O)C(=O)N(CCN(C)C)C=1CC1=CC=CC=C1 XTMHZHQBCWWIIM-UHFFFAOYSA-N 0.000 claims 1
- PLHZKXWJRBNGDQ-UHFFFAOYSA-N 2-benzyl-n-[(2,3-dimethoxyphenyl)methyl]-1-[2-(dimethylamino)ethyl]-5-hydroxy-6-oxopyrimidine-4-carboxamide Chemical compound COC1=CC=CC(CNC(=O)C2=C(C(=O)N(CCN(C)C)C(CC=3C=CC=CC=3)=N2)O)=C1OC PLHZKXWJRBNGDQ-UHFFFAOYSA-N 0.000 claims 1
- NLYAAFCETJWSJX-UHFFFAOYSA-N 2-benzyl-n-[(4-fluorophenyl)methyl]-5-hydroxy-1-(2-morpholin-4-ylethyl)-6-oxopyrimidine-4-carboxamide Chemical compound C1COCCN1CCN1C(=O)C(O)=C(C(=O)NCC=2C=CC(F)=CC=2)N=C1CC1=CC=CC=C1 NLYAAFCETJWSJX-UHFFFAOYSA-N 0.000 claims 1
- JNKFHHOAAJXOCU-UHFFFAOYSA-N 2-benzyl-n-[(4-fluorophenyl)methyl]-5-hydroxy-6-oxo-1-(2-piperidin-1-ylethyl)pyrimidine-4-carboxamide Chemical compound C1CCCCN1CCN1C(=O)C(O)=C(C(=O)NCC=2C=CC(F)=CC=2)N=C1CC1=CC=CC=C1 JNKFHHOAAJXOCU-UHFFFAOYSA-N 0.000 claims 1
- QSFZJORDXYWNDW-UHFFFAOYSA-N 2-benzyl-n-[(4-fluorophenyl)methyl]-5-hydroxy-6-oxo-1-(2-pyrrolidin-1-ylethyl)pyrimidine-4-carboxamide Chemical compound C1CCCN1CCN1C(=O)C(O)=C(C(=O)NCC=2C=CC(F)=CC=2)N=C1CC1=CC=CC=C1 QSFZJORDXYWNDW-UHFFFAOYSA-N 0.000 claims 1
- 125000000984 3-chloro-4-fluorobenzyl group Chemical group [H]C1=C(F)C(Cl)=C([H])C(=C1[H])C([H])([H])* 0.000 claims 1
- 125000004195 4-methylpiperazin-1-yl group Chemical group [H]C([H])([H])N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 claims 1
- OVXFBHJZCYLRFI-UHFFFAOYSA-N 4-n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-2-n-(2-morpholin-4-ylethyl)-6-oxopyrimidine-2,4-dicarboxamide Chemical compound OC=1C(=O)N(C)C(C(=O)NCCN2CCOCC2)=NC=1C(=O)NCC1=CC=C(F)C=C1 OVXFBHJZCYLRFI-UHFFFAOYSA-N 0.000 claims 1
- JQIPHXBYCSUSNI-UHFFFAOYSA-N 4-n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxo-2-n-(pyridin-2-ylmethyl)pyrimidine-2,4-dicarboxamide Chemical compound OC=1C(=O)N(C)C(C(=O)NCC=2N=CC=CC=2)=NC=1C(=O)NCC1=CC=C(F)C=C1 JQIPHXBYCSUSNI-UHFFFAOYSA-N 0.000 claims 1
- VLSUJTHPJBSFSZ-FCHUYYIVSA-N 5-hydroxy-n-[(1r,2s)-2-hydroxy-2,3-dihydro-1h-inden-1-yl]-1-methyl-2-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]-6-oxopyrimidine-4-carboxamide Chemical compound C1CN(C)CCN1CC1=CC=C(C=2N(C(=O)C(O)=C(C(=O)N[C@@H]3C4=CC=CC=C4C[C@@H]3O)N=2)C)C=C1 VLSUJTHPJBSFSZ-FCHUYYIVSA-N 0.000 claims 1
- 208000030507 AIDS Diseases 0.000 claims 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 1
- 108010002459 HIV Integrase Proteins 0.000 claims 1
- BXDZOYLPNAIDOC-UHFFFAOYSA-N N-[5-[(5-tert-butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]-1-[2-[2-[2-[2-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethoxy]ethoxy]ethoxy]ethylamino]-2-oxoethyl]piperidine-4-carboxamide Chemical compound CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCN(CC(=O)NCCOCCOCCOCCNc4cccc5C(=O)N(C6CCC(=O)NC6=O)C(=O)c45)CC3)s2)o1 BXDZOYLPNAIDOC-UHFFFAOYSA-N 0.000 claims 1
- 150000001204 N-oxides Chemical class 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 125000000304 alkynyl group Chemical group 0.000 claims 1
- 125000004429 atom Chemical group 0.000 claims 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 claims 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 1
- 229910052794 bromium Inorganic materials 0.000 claims 1
- 229910052801 chlorine Inorganic materials 0.000 claims 1
- 239000000460 chlorine Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 229910052731 fluorine Inorganic materials 0.000 claims 1
- 239000011737 fluorine Substances 0.000 claims 1
- 125000001153 fluoro group Chemical group F* 0.000 claims 1
- 125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 125000002911 monocyclic heterocycle group Chemical group 0.000 claims 1
- KBWNGLRCTYSSQQ-UHFFFAOYSA-N n'-[2-[4-[(4-fluorophenyl)methylcarbamoyl]-5-hydroxy-1-methyl-6-oxopyrimidin-2-yl]propan-2-yl]-n,n,n'-trimethyloxamide Chemical compound O=C1N(C)C(C(C)(C)N(C)C(=O)C(=O)N(C)C)=NC(C(=O)NCC=2C=CC(F)=CC=2)=C1O KBWNGLRCTYSSQQ-UHFFFAOYSA-N 0.000 claims 1
- PJPSTVMAIWIQLO-UHFFFAOYSA-N n-[(2,3-dimethoxyphenyl)methyl]-1-[2-(dimethylamino)ethyl]-5-hydroxy-6-oxopyrimidine-4-carboxamide Chemical compound COC1=CC=CC(CNC(=O)C2=C(C(=O)N(CCN(C)C)C=N2)O)=C1OC PJPSTVMAIWIQLO-UHFFFAOYSA-N 0.000 claims 1
- BQOFAQHGSONMDQ-UHFFFAOYSA-N n-[(2,3-dimethoxyphenyl)methyl]-2-[4-[(dimethylamino)methyl]phenyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound COC1=CC=CC(CNC(=O)C2=C(C(=O)N(C)C(C=3C=CC(CN(C)C)=CC=3)=N2)O)=C1OC BQOFAQHGSONMDQ-UHFFFAOYSA-N 0.000 claims 1
- WHZASYFZUVRFBL-UHFFFAOYSA-N n-[(2,3-dimethoxyphenyl)methyl]-5-hydroxy-1-methyl-2-(4-methylphenyl)-6-oxopyrimidine-4-carboxamide Chemical compound COC1=CC=CC(CNC(=O)C2=C(C(=O)N(C)C(C=3C=CC(C)=CC=3)=N2)O)=C1OC WHZASYFZUVRFBL-UHFFFAOYSA-N 0.000 claims 1
- QYJBDRMUCWAECJ-UHFFFAOYSA-N n-[(2,3-dimethoxyphenyl)methyl]-5-hydroxy-1-methyl-2-[4-(morpholin-4-ylmethyl)phenyl]-6-oxopyrimidine-4-carboxamide Chemical compound COC1=CC=CC(CNC(=O)C2=C(C(=O)N(C)C(C=3C=CC(CN4CCOCC4)=CC=3)=N2)O)=C1OC QYJBDRMUCWAECJ-UHFFFAOYSA-N 0.000 claims 1
- BIAXQJCWGFBAQS-UHFFFAOYSA-N n-[(2,3-dimethoxyphenyl)methyl]-5-hydroxy-1-methyl-6-oxo-2-[1-(pyridazine-3-carbonyl)pyrrolidin-2-yl]pyrimidine-4-carboxamide Chemical compound COC1=CC=CC(CNC(=O)C2=C(C(=O)N(C)C(C3N(CCC3)C(=O)C=3N=NC=CC=3)=N2)O)=C1OC BIAXQJCWGFBAQS-UHFFFAOYSA-N 0.000 claims 1
- BAZTZMIOXGDUNX-UHFFFAOYSA-N n-[(2,3-dimethoxyphenyl)methyl]-5-hydroxy-1-methyl-6-oxo-2-[4-(pyrrolidin-1-ylmethyl)phenyl]pyrimidine-4-carboxamide Chemical compound COC1=CC=CC(CNC(=O)C2=C(C(=O)N(C)C(C=3C=CC(CN4CCCC4)=CC=3)=N2)O)=C1OC BAZTZMIOXGDUNX-UHFFFAOYSA-N 0.000 claims 1
- FNOJESHMENCQMW-UHFFFAOYSA-N n-[(2,3-dimethoxyphenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound COC1=CC=CC(CNC(=O)C2=C(C(=O)N(C)C=N2)O)=C1OC FNOJESHMENCQMW-UHFFFAOYSA-N 0.000 claims 1
- CESLPBRSAXLQJA-UHFFFAOYSA-N n-[(2,3-dimethoxyphenyl)methyl]-5-hydroxy-6-oxo-1-(pyridin-3-ylmethyl)pyrimidine-4-carboxamide Chemical compound COC1=CC=CC(CNC(=O)C2=C(C(=O)N(CC=3C=NC=CC=3)C=N2)O)=C1OC CESLPBRSAXLQJA-UHFFFAOYSA-N 0.000 claims 1
- WFLVTENZMIIAFI-UHFFFAOYSA-N n-[(2-ethoxyphenyl)methyl]-5-hydroxy-1-methyl-2-(4-methylphenyl)-6-oxopyrimidine-4-carboxamide Chemical compound CCOC1=CC=CC=C1CNC(=O)C1=C(O)C(=O)N(C)C(C=2C=CC(C)=CC=2)=N1 WFLVTENZMIIAFI-UHFFFAOYSA-N 0.000 claims 1
- UCPLHPKMURVGGO-UHFFFAOYSA-N n-[(3-chloro-4-methylphenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound C1=C(Cl)C(C)=CC=C1CNC(=O)C1=C(O)C(=O)N(C)C=N1 UCPLHPKMURVGGO-UHFFFAOYSA-N 0.000 claims 1
- HFRWMNSTLIVJSP-UHFFFAOYSA-N n-[(4-fluoro-2-methylsulfonylphenyl)methyl]-5-hydroxy-1-methyl-6-oxo-2-[1-(pyrazine-2-carbonyl)pyrrolidin-2-yl]pyrimidine-4-carboxamide Chemical compound OC=1C(=O)N(C)C(C2N(CCC2)C(=O)C=2N=CC=NC=2)=NC=1C(=O)NCC1=CC=C(F)C=C1S(C)(=O)=O HFRWMNSTLIVJSP-UHFFFAOYSA-N 0.000 claims 1
- IHWDAMSGXKEULZ-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-2-[(4-formylpiperazin-1-yl)-phenylmethyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound OC=1C(=O)N(C)C(C(N2CCN(CC2)C=O)C=2C=CC=CC=2)=NC=1C(=O)NCC1=CC=C(F)C=C1 IHWDAMSGXKEULZ-UHFFFAOYSA-N 0.000 claims 1
- WIGVCUMLRIUNJO-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-2-[4-[[(4-fluorophenyl)methylamino]methyl]phenyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound OC=1C(=O)N(C)C(C=2C=CC(CNCC=3C=CC(F)=CC=3)=CC=2)=NC=1C(=O)NCC1=CC=C(F)C=C1 WIGVCUMLRIUNJO-UHFFFAOYSA-N 0.000 claims 1
- VZCYYKRGROYDTL-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-5-hydroxy-1-(2-hydroxy-3-morpholin-4-ylpropyl)-6-oxopyrimidine-4-carboxamide Chemical compound C1=NC(C(=O)NCC=2C=CC(F)=CC=2)=C(O)C(=O)N1CC(O)CN1CCOCC1 VZCYYKRGROYDTL-UHFFFAOYSA-N 0.000 claims 1
- LDLGMIZBMFPVLL-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-5-hydroxy-1-[[2-(morpholin-4-ylmethyl)phenyl]methyl]-6-oxopyrimidine-4-carboxamide Chemical compound O=C1C(O)=C(C(=O)NCC=2C=CC(F)=CC=2)N=CN1CC1=CC=CC=C1CN1CCOCC1 LDLGMIZBMFPVLL-UHFFFAOYSA-N 0.000 claims 1
- RAIDSLCQTZMEBV-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-5-hydroxy-1-[[3-(morpholin-4-ylmethyl)phenyl]methyl]-6-oxopyrimidine-4-carboxamide Chemical compound O=C1C(O)=C(C(=O)NCC=2C=CC(F)=CC=2)N=CN1CC(C=1)=CC=CC=1CN1CCOCC1 RAIDSLCQTZMEBV-UHFFFAOYSA-N 0.000 claims 1
- OMBWSUXPQJRTRC-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-5-hydroxy-1-[[3-[(4-methylpiperazin-1-yl)methyl]phenyl]methyl]-6-oxopyrimidine-4-carboxamide Chemical compound C1CN(C)CCN1CC1=CC=CC(CN2C(C(O)=C(C(=O)NCC=3C=CC(F)=CC=3)N=C2)=O)=C1 OMBWSUXPQJRTRC-UHFFFAOYSA-N 0.000 claims 1
- JJHQXTYDTXEARX-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-5-hydroxy-1-[[4-(morpholin-4-ylmethyl)phenyl]methyl]-6-oxopyrimidine-4-carboxamide Chemical compound O=C1C(O)=C(C(=O)NCC=2C=CC(F)=CC=2)N=CN1CC(C=C1)=CC=C1CN1CCOCC1 JJHQXTYDTXEARX-UHFFFAOYSA-N 0.000 claims 1
- JMPKVGUHFRMOJB-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-2-(1-methyl-2,3-dihydroindol-2-yl)-6-oxopyrimidine-4-carboxamide Chemical compound C1C2=CC=CC=C2N(C)C1C(N(C(=O)C=1O)C)=NC=1C(=O)NCC1=CC=C(F)C=C1 JMPKVGUHFRMOJB-UHFFFAOYSA-N 0.000 claims 1
- JDCVYDDPFWSXIY-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-2-(1-methyl-3,4-dihydro-2h-quinolin-2-yl)-6-oxopyrimidine-4-carboxamide Chemical compound C1CC2=CC=CC=C2N(C)C1C(N(C(=O)C=1O)C)=NC=1C(=O)NCC1=CC=C(F)C=C1 JDCVYDDPFWSXIY-UHFFFAOYSA-N 0.000 claims 1
- MWPWGZXQCAMTQA-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-2-(1-methyl-4-methylsulfonylpiperazin-2-yl)-6-oxopyrimidine-4-carboxamide Chemical compound CN1CCN(S(C)(=O)=O)CC1C1=NC(C(=O)NCC=2C=CC(F)=CC=2)=C(O)C(=O)N1C MWPWGZXQCAMTQA-UHFFFAOYSA-N 0.000 claims 1
- SCQMBPMJBXEQHB-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-2-(1-methyl-4-propan-2-ylsulfonylpiperazin-2-yl)-6-oxopyrimidine-4-carboxamide Chemical compound C1N(S(=O)(=O)C(C)C)CCN(C)C1C1=NC(C(=O)NCC=2C=CC(F)=CC=2)=C(O)C(=O)N1C SCQMBPMJBXEQHB-UHFFFAOYSA-N 0.000 claims 1
- AHOZQSJDGWQTGZ-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-2-(1-methylpiperazin-2-yl)-6-oxopyrimidine-4-carboxamide Chemical compound CN1CCNCC1C1=NC(C(=O)NCC=2C=CC(F)=CC=2)=C(O)C(=O)N1C AHOZQSJDGWQTGZ-UHFFFAOYSA-N 0.000 claims 1
- HGPPRMHXEAZMCS-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-2-(1-methylpiperidin-2-yl)-6-oxopyrimidine-4-carboxamide Chemical compound CN1CCCCC1C1=NC(C(=O)NCC=2C=CC(F)=CC=2)=C(O)C(=O)N1C HGPPRMHXEAZMCS-UHFFFAOYSA-N 0.000 claims 1
- OBOZOOUMEWSYHT-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-2-(1-methylpyrrolidin-2-yl)-6-oxopyrimidine-4-carboxamide Chemical compound CN1CCCC1C1=NC(C(=O)NCC=2C=CC(F)=CC=2)=C(O)C(=O)N1C OBOZOOUMEWSYHT-UHFFFAOYSA-N 0.000 claims 1
- VKPSGRZTOPVKNO-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-2-(1-methylsulfonylpyrrolidin-2-yl)-6-oxopyrimidine-4-carboxamide Chemical compound OC=1C(=O)N(C)C(C2N(CCC2)S(C)(=O)=O)=NC=1C(=O)NCC1=CC=C(F)C=C1 VKPSGRZTOPVKNO-UHFFFAOYSA-N 0.000 claims 1
- XELOXWAFQQJLHA-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-2-(2-methyl-3,4-dihydro-1h-isoquinolin-3-yl)-6-oxopyrimidine-4-carboxamide Chemical compound CN1CC2=CC=CC=C2CC1C(N(C(=O)C=1O)C)=NC=1C(=O)NCC1=CC=C(F)C=C1 XELOXWAFQQJLHA-UHFFFAOYSA-N 0.000 claims 1
- PNWYCMYUUHGLBX-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-2-(2-morpholin-4-ylethyl)-6-oxopyrimidine-4-carboxamide Chemical compound N=1C(C(=O)NCC=2C=CC(F)=CC=2)=C(O)C(=O)N(C)C=1CCN1CCOCC1 PNWYCMYUUHGLBX-UHFFFAOYSA-N 0.000 claims 1
- WHVOMNUJJHPZEB-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-2-(4-methylphenyl)-6-oxopyrimidine-4-carboxamide Chemical compound C1=CC(C)=CC=C1C1=NC(C(=O)NCC=2C=CC(F)=CC=2)=C(O)C(=O)N1C WHVOMNUJJHPZEB-UHFFFAOYSA-N 0.000 claims 1
- RDPAQDWMABAMKG-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-2-(4-methylthiomorpholin-3-yl)-6-oxopyrimidine-4-carboxamide Chemical compound CN1CCSCC1C1=NC(C(=O)NCC=2C=CC(F)=CC=2)=C(O)C(=O)N1C RDPAQDWMABAMKG-UHFFFAOYSA-N 0.000 claims 1
- IEKQWIQTLCCVDM-UXHICEINSA-N n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-2-[(2s,4r)-1-methyl-4-phenylmethoxypyrrolidin-2-yl]-6-oxopyrimidine-4-carboxamide Chemical compound OC=1C(=O)N(C)C([C@@H]2C[C@H](CN2C)OCC=2C=CC=CC=2)=NC=1C(=O)NCC1=CC=C(F)C=C1 IEKQWIQTLCCVDM-UXHICEINSA-N 0.000 claims 1
- DXFBOOODWPDDKU-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-2-[1-(1-methylimidazole-2-carbonyl)pyrrolidin-2-yl]-6-oxopyrimidine-4-carboxamide Chemical compound CN1C=CN=C1C(=O)N1C(C=2N(C(=O)C(O)=C(C(=O)NCC=3C=CC(F)=CC=3)N=2)C)CCC1 DXFBOOODWPDDKU-UHFFFAOYSA-N 0.000 claims 1
- OZIINZFNOLCTGH-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-2-[1-(2-methylsulfonylacetyl)pyrrolidin-2-yl]-6-oxopyrimidine-4-carboxamide Chemical compound OC=1C(=O)N(C)C(C2N(CCC2)C(=O)CS(C)(=O)=O)=NC=1C(=O)NCC1=CC=C(F)C=C1 OZIINZFNOLCTGH-UHFFFAOYSA-N 0.000 claims 1
- SFQNKQIISLWOQM-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-2-[1-(2-morpholin-4-yl-2-oxoacetyl)pyrrolidin-2-yl]-6-oxopyrimidine-4-carboxamide Chemical compound OC=1C(=O)N(C)C(C2N(CCC2)C(=O)C(=O)N2CCOCC2)=NC=1C(=O)NCC1=CC=C(F)C=C1 SFQNKQIISLWOQM-UHFFFAOYSA-N 0.000 claims 1
- UPKYIGHUHLSDKC-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-2-[1-(4-methylmorpholine-3-carbonyl)pyrrolidin-2-yl]-6-oxopyrimidine-4-carboxamide Chemical compound CN1CCOCC1C(=O)N1C(C=2N(C(=O)C(O)=C(C(=O)NCC=3C=CC(F)=CC=3)N=2)C)CCC1 UPKYIGHUHLSDKC-UHFFFAOYSA-N 0.000 claims 1
- FEGGWFBDJDPHRP-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-2-[1-methyl-4-(1-methylimidazole-2-carbonyl)piperazin-2-yl]-6-oxopyrimidine-4-carboxamide Chemical compound CN1CCN(C(=O)C=2N(C=CN=2)C)CC1C(N(C(=O)C=1O)C)=NC=1C(=O)NCC1=CC=C(F)C=C1 FEGGWFBDJDPHRP-UHFFFAOYSA-N 0.000 claims 1
- DWNWXQVKMRJASU-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-2-[2-[(2-morpholin-4-yl-2-oxoacetyl)amino]propan-2-yl]-6-oxopyrimidine-4-carboxamide Chemical compound OC=1C(=O)N(C)C(C(C)(C)NC(=O)C(=O)N2CCOCC2)=NC=1C(=O)NCC1=CC=C(F)C=C1 DWNWXQVKMRJASU-UHFFFAOYSA-N 0.000 claims 1
- LGPINXWKVBCQRV-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-2-[4-(morpholin-4-ylmethyl)phenyl]-6-oxopyrimidine-4-carboxamide Chemical compound OC=1C(=O)N(C)C(C=2C=CC(CN3CCOCC3)=CC=2)=NC=1C(=O)NCC1=CC=C(F)C=C1 LGPINXWKVBCQRV-UHFFFAOYSA-N 0.000 claims 1
- WJCVTFVBTRMATJ-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxo-2-(1-propan-2-yl-2,3-dihydroindol-2-yl)pyrimidine-4-carboxamide Chemical compound C1C2=CC=CC=C2N(C(C)C)C1C(N(C(=O)C=1O)C)=NC=1C(=O)NCC1=CC=C(F)C=C1 WJCVTFVBTRMATJ-UHFFFAOYSA-N 0.000 claims 1
- DTHZLIPXZZDEAW-VWNXMTODSA-N n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxo-2-[(2s,4r)-4-phenylmethoxy-1-(pyridine-2-carbonyl)pyrrolidin-2-yl]pyrimidine-4-carboxamide Chemical compound OC=1C(=O)N(C)C([C@H]2N(C[C@@H](C2)OCC=2C=CC=CC=2)C(=O)C=2N=CC=CC=2)=NC=1C(=O)NCC1=CC=C(F)C=C1 DTHZLIPXZZDEAW-VWNXMTODSA-N 0.000 claims 1
- JQCTZTOUKRWUMV-MOPGFXCFSA-N n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxo-2-[(2s,4r)-4-phenylmethoxypyrrolidin-2-yl]pyrimidine-4-carboxamide Chemical compound OC=1C(=O)N(C)C([C@H]2NC[C@@H](C2)OCC=2C=CC=CC=2)=NC=1C(=O)NCC1=CC=C(F)C=C1 JQCTZTOUKRWUMV-MOPGFXCFSA-N 0.000 claims 1
- ZKWTZOXJHHNWIR-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxo-2-[1-(phenylcarbamoyl)pyrrolidin-2-yl]pyrimidine-4-carboxamide Chemical compound OC=1C(=O)N(C)C(C2N(CCC2)C(=O)NC=2C=CC=CC=2)=NC=1C(=O)NCC1=CC=C(F)C=C1 ZKWTZOXJHHNWIR-UHFFFAOYSA-N 0.000 claims 1
- ZONPXBUZHVJLDB-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxo-2-[1-(pyrazine-2-carbonyl)pyrrolidin-2-yl]pyrimidine-4-carboxamide Chemical compound OC=1C(=O)N(C)C(C2N(CCC2)C(=O)C=2N=CC=NC=2)=NC=1C(=O)NCC1=CC=C(F)C=C1 ZONPXBUZHVJLDB-UHFFFAOYSA-N 0.000 claims 1
- FMLGYBYNMDDGBV-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxo-2-[1-(pyridine-2-carbonyl)-2,3-dihydroindol-2-yl]pyrimidine-4-carboxamide Chemical compound OC=1C(=O)N(C)C(C2N(C3=CC=CC=C3C2)C(=O)C=2N=CC=CC=2)=NC=1C(=O)NCC1=CC=C(F)C=C1 FMLGYBYNMDDGBV-UHFFFAOYSA-N 0.000 claims 1
- KHJBWBNIGQBOFA-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxo-2-[1-(pyridine-2-carbonyl)-3,4-dihydro-2h-quinolin-2-yl]pyrimidine-4-carboxamide Chemical compound OC=1C(=O)N(C)C(C2N(C3=CC=CC=C3CC2)C(=O)C=2N=CC=CC=2)=NC=1C(=O)NCC1=CC=C(F)C=C1 KHJBWBNIGQBOFA-UHFFFAOYSA-N 0.000 claims 1
- VCOMLFPLSKDOPY-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxo-2-[1-(pyridine-2-carbonyl)piperidin-2-yl]pyrimidine-4-carboxamide Chemical compound OC=1C(=O)N(C)C(C2N(CCCC2)C(=O)C=2N=CC=CC=2)=NC=1C(=O)NCC1=CC=C(F)C=C1 VCOMLFPLSKDOPY-UHFFFAOYSA-N 0.000 claims 1
- BCCKQMVHHMROSZ-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxo-2-[1-(pyridine-2-carbonyl)pyrrolidin-2-yl]pyrimidine-4-carboxamide Chemical compound OC=1C(=O)N(C)C(C2N(CCC2)C(=O)C=2N=CC=CC=2)=NC=1C(=O)NCC1=CC=C(F)C=C1 BCCKQMVHHMROSZ-UHFFFAOYSA-N 0.000 claims 1
- DKAPDWBJGOHKGB-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxo-2-[1-(pyridine-3-carbonyl)pyrrolidin-2-yl]pyrimidine-4-carboxamide Chemical compound OC=1C(=O)N(C)C(C2N(CCC2)C(=O)C=2C=NC=CC=2)=NC=1C(=O)NCC1=CC=C(F)C=C1 DKAPDWBJGOHKGB-UHFFFAOYSA-N 0.000 claims 1
- ROOWWHJTOPZXFJ-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxo-2-[1-(pyridine-4-carbonyl)pyrrolidin-2-yl]pyrimidine-4-carboxamide Chemical compound OC=1C(=O)N(C)C(C2N(CCC2)C(=O)C=2C=CN=CC=2)=NC=1C(=O)NCC1=CC=C(F)C=C1 ROOWWHJTOPZXFJ-UHFFFAOYSA-N 0.000 claims 1
- GSMJFDGKMLBRQW-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxo-2-[1-(pyrimidine-4-carbonyl)pyrrolidin-2-yl]pyrimidine-4-carboxamide Chemical compound OC=1C(=O)N(C)C(C2N(CCC2)C(=O)C=2N=CN=CC=2)=NC=1C(=O)NCC1=CC=C(F)C=C1 GSMJFDGKMLBRQW-UHFFFAOYSA-N 0.000 claims 1
- NNZJZIUJMQGKMH-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxo-2-[1-(pyrimidine-5-carbonyl)pyrrolidin-2-yl]pyrimidine-4-carboxamide Chemical compound OC=1C(=O)N(C)C(C2N(CCC2)C(=O)C=2C=NC=NC=2)=NC=1C(=O)NCC1=CC=C(F)C=C1 NNZJZIUJMQGKMH-UHFFFAOYSA-N 0.000 claims 1
- FUQUAVVKWLBUSD-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxo-2-[2-(1h-pyrazole-5-carbonylamino)propan-2-yl]pyrimidine-4-carboxamide Chemical compound OC=1C(=O)N(C)C(C(C)(C)NC(=O)C=2NN=CC=2)=NC=1C(=O)NCC1=CC=C(F)C=C1 FUQUAVVKWLBUSD-UHFFFAOYSA-N 0.000 claims 1
- YUVSRXQXTXNGCH-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxo-2-[4-(piperidin-1-ylmethyl)phenyl]pyrimidine-4-carboxamide Chemical compound OC=1C(=O)N(C)C(C=2C=CC(CN3CCCCC3)=CC=2)=NC=1C(=O)NCC1=CC=C(F)C=C1 YUVSRXQXTXNGCH-UHFFFAOYSA-N 0.000 claims 1
- SMNKZAYRFNJSOA-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxo-2-[4-(pyrrolidin-1-ylmethyl)phenyl]pyrimidine-4-carboxamide Chemical compound OC=1C(=O)N(C)C(C=2C=CC(CN3CCCC3)=CC=2)=NC=1C(=O)NCC1=CC=C(F)C=C1 SMNKZAYRFNJSOA-UHFFFAOYSA-N 0.000 claims 1
- YKVAOEPIROGDBX-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxo-2-[4-[(2-pyridin-3-ylpiperidin-1-yl)methyl]phenyl]pyrimidine-4-carboxamide Chemical compound OC=1C(=O)N(C)C(C=2C=CC(CN3C(CCCC3)C=3C=NC=CC=3)=CC=2)=NC=1C(=O)NCC1=CC=C(F)C=C1 YKVAOEPIROGDBX-UHFFFAOYSA-N 0.000 claims 1
- VINXTVGDLLRAIH-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxo-2-[4-phenylmethoxy-1-(pyrazine-2-carbonyl)pyrrolidin-2-yl]pyrimidine-4-carboxamide Chemical compound OC=1C(=O)N(C)C(C2N(CC(C2)OCC=2C=CC=CC=2)C(=O)C=2N=CC=NC=2)=NC=1C(=O)NCC1=CC=C(F)C=C1 VINXTVGDLLRAIH-UHFFFAOYSA-N 0.000 claims 1
- NFUZOHATXLLROE-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxo-2-[phenyl-(pyridin-3-ylmethylamino)methyl]pyrimidine-4-carboxamide Chemical compound OC=1C(=O)N(C)C(C(NCC=2C=NC=CC=2)C=2C=CC=CC=2)=NC=1C(=O)NCC1=CC=C(F)C=C1 NFUZOHATXLLROE-UHFFFAOYSA-N 0.000 claims 1
- WKGVKPRDCRSQCI-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxo-2-pyrrolidin-2-ylpyrimidine-4-carboxamide Chemical compound OC=1C(=O)N(C)C(C2NCCC2)=NC=1C(=O)NCC1=CC=C(F)C=C1 WKGVKPRDCRSQCI-UHFFFAOYSA-N 0.000 claims 1
- OVRFHKWFMGUJFC-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound O=C1N(C)C=NC(C(=O)NCC=2C=CC(F)=CC=2)=C1O OVRFHKWFMGUJFC-UHFFFAOYSA-N 0.000 claims 1
- OAMCENINXMAPLY-OLZOCXBDSA-N n-[(4-fluorophenyl)methyl]-5-hydroxy-2-[(2s,4r)-4-hydroxy-1-methylpyrrolidin-2-yl]-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound CN1C[C@H](O)C[C@H]1C1=NC(C(=O)NCC=2C=CC(F)=CC=2)=C(O)C(=O)N1C OAMCENINXMAPLY-OLZOCXBDSA-N 0.000 claims 1
- BFRUIGGTNRFWAC-NEPJUHHUSA-N n-[(4-fluorophenyl)methyl]-5-hydroxy-2-[(2s,4r)-4-hydroxypyrrolidin-2-yl]-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound OC=1C(=O)N(C)C([C@H]2NC[C@H](O)C2)=NC=1C(=O)NCC1=CC=C(F)C=C1 BFRUIGGTNRFWAC-NEPJUHHUSA-N 0.000 claims 1
- PZJGDNRDXHDJEG-KGLIPLIRSA-N n-[(4-fluorophenyl)methyl]-5-hydroxy-2-[(2s,4r)-4-methoxy-1-methylpyrrolidin-2-yl]-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound CN1C[C@H](OC)C[C@H]1C1=NC(C(=O)NCC=2C=CC(F)=CC=2)=C(O)C(=O)N1C PZJGDNRDXHDJEG-KGLIPLIRSA-N 0.000 claims 1
- KVQATFBBHKUIDY-KBPBESRZSA-N n-[(4-fluorophenyl)methyl]-5-hydroxy-2-[(2s,4s)-4-(methanesulfonamido)-1-methylpyrrolidin-2-yl]-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound CN1C[C@@H](NS(C)(=O)=O)C[C@H]1C1=NC(C(=O)NCC=2C=CC(F)=CC=2)=C(O)C(=O)N1C KVQATFBBHKUIDY-KBPBESRZSA-N 0.000 claims 1
- GZEZCKVJTNBMTI-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-5-hydroxy-2-[2-(1h-imidazole-5-carbonylamino)propan-2-yl]-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound OC=1C(=O)N(C)C(C(C)(C)NC(=O)C=2NC=NC=2)=NC=1C(=O)NCC1=CC=C(F)C=C1 GZEZCKVJTNBMTI-UHFFFAOYSA-N 0.000 claims 1
- APKWYHRVCIBHSG-OAQYLSRUSA-N n-[(4-fluorophenyl)methyl]-5-hydroxy-2-[4-[[(2r)-2-(methoxymethyl)pyrrolidin-1-yl]methyl]phenyl]-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound COC[C@H]1CCCN1CC1=CC=C(C=2N(C(=O)C(O)=C(C(=O)NCC=3C=CC(F)=CC=3)N=2)C)C=C1 APKWYHRVCIBHSG-OAQYLSRUSA-N 0.000 claims 1
- APKWYHRVCIBHSG-NRFANRHFSA-N n-[(4-fluorophenyl)methyl]-5-hydroxy-2-[4-[[(2s)-2-(methoxymethyl)pyrrolidin-1-yl]methyl]phenyl]-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound COC[C@@H]1CCCN1CC1=CC=C(C=2N(C(=O)C(O)=C(C(=O)NCC=3C=CC(F)=CC=3)N=2)C)C=C1 APKWYHRVCIBHSG-NRFANRHFSA-N 0.000 claims 1
- LTKFWLSMGAXVJZ-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-5-hydroxy-6-oxo-1-(pyridin-3-ylmethyl)pyrimidine-4-carboxamide Chemical compound O=C1C(O)=C(C(=O)NCC=2C=CC(F)=CC=2)N=CN1CC1=CC=CN=C1 LTKFWLSMGAXVJZ-UHFFFAOYSA-N 0.000 claims 1
- NARKILMWEQIHTF-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-5-hydroxy-6-oxo-1-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]pyrimidine-4-carboxamide Chemical compound O=C1C(O)=C(C(=O)NCC=2C=CC(F)=CC=2)N=CN1CC(C=1)=CC=CC=1CN1CCCC1 NARKILMWEQIHTF-UHFFFAOYSA-N 0.000 claims 1
- PTNYZJGTUPWTLH-UHFFFAOYSA-N n-[2-[4-[(4-fluoro-2-methylsulfonylphenyl)methylcarbamoyl]-5-hydroxy-1-methyl-6-oxopyrimidin-2-yl]propan-2-yl]-n',n'-dimethyloxamide Chemical compound O=C1N(C)C(C(C)(C)NC(=O)C(=O)N(C)C)=NC(C(=O)NCC=2C(=CC(F)=CC=2)S(C)(=O)=O)=C1O PTNYZJGTUPWTLH-UHFFFAOYSA-N 0.000 claims 1
- KLXJQXWSAKXTRW-UHFFFAOYSA-N n-[2-[4-[(4-fluoro-2-methylsulfonylphenyl)methylcarbamoyl]-5-hydroxy-1-methyl-6-oxopyrimidin-2-yl]propan-2-yl]imidazo[2,1-b][1,3]thiazole-6-carboxamide Chemical compound OC=1C(=O)N(C)C(C(C)(C)NC(=O)C=2N=C3SC=CN3C=2)=NC=1C(=O)NCC1=CC=C(F)C=C1S(C)(=O)=O KLXJQXWSAKXTRW-UHFFFAOYSA-N 0.000 claims 1
- WGLILLWPZIBWTQ-UHFFFAOYSA-N n-[2-[4-[(4-fluorophenyl)methylcarbamoyl]-5-hydroxy-1-methyl-6-oxopyrimidin-2-yl]propan-2-yl]-n',n'-dimethyloxamide Chemical compound O=C1N(C)C(C(C)(C)NC(=O)C(=O)N(C)C)=NC(C(=O)NCC=2C=CC(F)=CC=2)=C1O WGLILLWPZIBWTQ-UHFFFAOYSA-N 0.000 claims 1
- NULNZGKAFCBDFD-UHFFFAOYSA-N n-[2-[4-[(4-fluorophenyl)methylcarbamoyl]-5-hydroxy-1-methyl-6-oxopyrimidin-2-yl]propan-2-yl]imidazo[2,1-b][1,3]thiazole-6-carboxamide Chemical compound OC=1C(=O)N(C)C(C(C)(C)NC(=O)C=2N=C3SC=CN3C=2)=NC=1C(=O)NCC1=CC=C(F)C=C1 NULNZGKAFCBDFD-UHFFFAOYSA-N 0.000 claims 1
- NGVSQIPBPYPCFN-UHFFFAOYSA-N n-[[4-fluoro-2-(trifluoromethyl)phenyl]methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide Chemical compound O=C1N(C)C=NC(C(=O)NCC=2C(=CC(F)=CC=2)C(F)(F)F)=C1O NGVSQIPBPYPCFN-UHFFFAOYSA-N 0.000 claims 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 125000004574 piperidin-2-yl group Chemical group N1C(CCCC1)* 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- 125000001712 tetrahydronaphthyl group Chemical group C1(CCCC2=CC=CC=C12)* 0.000 claims 1
- 0 *C(N(*)C1=O)=NC(C(N(*)*)=O)=C1O Chemical compound *C(N(*)C1=O)=NC(C(N(*)*)=O)=C1O 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33956801P | 2001-10-26 | 2001-10-26 | |
| US36219102P | 2002-03-06 | 2002-03-06 | |
| PCT/GB2002/004753 WO2003035077A1 (en) | 2001-10-26 | 2002-10-21 | N-substituted hydroxypyrimidinone carboxamide inhibitors of hiv integrase |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005511543A JP2005511543A (ja) | 2005-04-28 |
| JP2005511543A5 true JP2005511543A5 (enExample) | 2006-09-28 |
| JP3927175B2 JP3927175B2 (ja) | 2007-06-06 |
Family
ID=26991691
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003537644A Expired - Lifetime JP3927175B2 (ja) | 2001-10-26 | 2002-10-21 | Ｎ−置換ヒドロキシピリミジノンカルボキサミド系ｈｉｖインテグラーゼ阻害薬 |
Country Status (34)
Families Citing this family (135)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6545004B1 (en) | 1999-10-27 | 2003-04-08 | Cytokinetics, Inc. | Methods and compositions utilizing quinazolinones |
| US7230000B1 (en) | 1999-10-27 | 2007-06-12 | Cytokinetics, Incorporated | Methods and compositions utilizing quinazolinones |
| WO2002030426A1 (en) | 2000-10-12 | 2002-04-18 | Merck & Co., Inc. | Aza- and polyaza-naphthalenyl-carboxamides useful as hiv integrase inhibitors |
| NZ525088A (en) | 2000-10-12 | 2004-11-26 | Merck & Co Inc | Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors |
| JP2004517860A (ja) | 2000-10-12 | 2004-06-17 | メルク エンド カムパニー インコーポレーテッド | Ｈｉｖインテグラーゼ阻害薬として有用なアザ−およびポリアザ−ナフタレニルカルボキサミド類 |
| DK2266958T1 (da) * | 2001-08-10 | 2016-04-04 | Shionogi & Co | Antiviralt middel |
| AR036256A1 (es) | 2001-08-17 | 2004-08-25 | Merck & Co Inc | Sal sodica de un inhibidor de integrasa del vih, procesos para su preparacion, composiciones farmaceuticas que lo contienen y su uso para la manufactura de un medicamento |
| AU2002334205B2 (en) * | 2001-10-26 | 2007-07-05 | Istituto Di Ricerche Di Biologia Molecolara P. Angeletti Spa | Dihydroxypyrimidine carboxamide inhibitors of HIV integrase |
| SI1441735T1 (sl) * | 2001-10-26 | 2006-06-30 | Angeletti P Ist Richerche Bio | N-substituirani hidroksipirimidinon-karboksamidniinhibitorji HIV-integraze |
| JP2005529076A (ja) | 2002-02-15 | 2005-09-29 | サイトキネティクス・インコーポレーテッド | キナゾリノンの合成 |
| JP4494020B2 (ja) | 2002-03-15 | 2010-06-30 | メルク・シャープ・エンド・ドーム・コーポレイション | Ｈｉｖインテグラーゼ阻害剤として有用なｎ−（置換ベンジル）−８−ヒドロキシ−１，６−ナフチリジン−７−カルボキサミド |
| CN100491358C (zh) * | 2002-05-09 | 2009-05-27 | 赛特凯恩蒂克公司 | 嘧啶酮类化合物、组合物及方法 |
| US7214800B2 (en) | 2002-05-09 | 2007-05-08 | Cytokinetics, Inc. | Compounds, compositions, and methods |
| JP2005536475A (ja) | 2002-05-23 | 2005-12-02 | サイトキネティクス・インコーポレーテッド | 化合物、組成物、および方法 |
| CA2483627A1 (en) * | 2002-05-23 | 2003-12-04 | Merck & Co., Inc. | Mitotic kinesin inhibitors |
| WO2004004657A2 (en) | 2002-07-09 | 2004-01-15 | Bristol-Myers Squibb Company | Hiv integrase inhibitors |
| AU2003256805A1 (en) | 2002-07-23 | 2004-02-09 | Cytokinetics, Inc. | Compounds compositions and methods |
| JP2005538184A (ja) | 2002-09-11 | 2005-12-15 | メルク エンド カムパニー インコーポレーテッド | Ｈｉｖインテグラーゼ阻害剤として有用な８−ヒドロキシ−１−オキソ−テトラヒドロピロロピラジン化合物 |
| EP1549315A4 (en) | 2002-09-11 | 2007-05-23 | Merck & Co Inc | DIHYDROXYPYRIDOPYRAZINE-1,6-DION COMPOUNDS AS HIV INTEGRASE INHIBITORS |
| WO2004034972A2 (en) | 2002-09-30 | 2004-04-29 | Cytokinetics, Inc. | Compounds, compositions, and methods |
| AU2003292437A1 (en) * | 2002-12-27 | 2004-07-22 | Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa | Tetrahydro-4h-pyrido(1,2-a)pyrimidines and related compounds useful as hiv integrase inhibitors |
| US7135467B2 (en) * | 2003-01-13 | 2006-11-14 | Bristol-Myers Squibb Company | HIV integrase inhibitors |
| US7037908B2 (en) | 2003-04-24 | 2006-05-02 | Bristol-Myers Squibb Company | HIV integrase inhibitors |
| TW200510425A (en) | 2003-08-13 | 2005-03-16 | Japan Tobacco Inc | Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor |
| EP1677599A4 (en) | 2003-10-20 | 2008-10-22 | Merck & Co Inc | HYDROXYPYRIDOPYRROLOPYRAZINDION COMPOUNDS AS HIV INTEGRASE INHIBITORS |
| US20050090668A1 (en) * | 2003-10-28 | 2005-04-28 | Dreher Spencer D. | Preparation of 5-hydroxy-6-oxo-1,6-dihydropyrimidine compounds |
| US7439254B2 (en) | 2003-12-08 | 2008-10-21 | Cytokinetics, Inc. | Compounds, compositions, and methods |
| AR046938A1 (es) * | 2003-12-12 | 2006-01-04 | Merck & Co Inc | Procedimiento para preparar hexahidropirimido[1,2-a]azepin-2-carboxilatos y compuetos similares |
| EP1697331A4 (en) | 2003-12-19 | 2010-08-04 | Merck Sharp & Dohme | INHIBITORS OF MITOTIC KINESINE |
| TW200526635A (en) * | 2003-12-22 | 2005-08-16 | Shionogi & Co | Hydroxypyrimidinone derivative having HIV integrase inhibitory activity |
| KR20060124701A (ko) * | 2004-01-12 | 2006-12-05 | 길리애드 사이언시즈, 인코포레이티드 | 피리미딜 포스포네이트 항바이러스성 화합물 및 그의 사용방법 |
| AU2005220767A1 (en) | 2004-03-09 | 2005-09-22 | Merck & Co., Inc. | HIV integrase inhibitors |
| AU2005227258A1 (en) | 2004-03-09 | 2005-10-06 | Merck & Co., Inc. | HIV integrase inhibitors |
| CA2558026C (en) * | 2004-03-09 | 2010-12-14 | Merck & Co., Inc. | Hiv integrase inhibitors |
| CN1930161A (zh) | 2004-03-09 | 2007-03-14 | P·安杰莱蒂分子生物学研究所 | Hiv整合酶抑制剂 |
| CN1964975B (zh) * | 2004-05-07 | 2011-11-30 | 默沙东公司 | Hiv整合酶抑制剂 |
| US7273859B2 (en) | 2004-05-12 | 2007-09-25 | Bristol-Myers Squibb Company | HIV integrase inhibitors: cyclic pyrimidinone compounds |
| US7115601B2 (en) * | 2004-05-18 | 2006-10-03 | Bristol-Myers Squibb Company | HIV integrase inhibitors |
| US7192948B2 (en) | 2004-05-28 | 2007-03-20 | Bristol-Myers Squibb Company | Bicyclic heterocycles as HIV integrase inhibitors |
| US7173022B2 (en) | 2004-05-28 | 2007-02-06 | Bristol-Myers Squibb Company | Bicyclic heterocycles as HIV integrase inhibitors |
| US7176196B2 (en) | 2004-05-28 | 2007-02-13 | Bristol-Myers Squibb Company | Bicyclic heterocycles as HIV integrase inhibitors |
| US7157447B2 (en) | 2004-05-28 | 2007-01-02 | Bristol-Myers Squibb Company | Bicyclic heterocycles as HIV integrase inhibitors |
| CN101146540A (zh) | 2004-06-09 | 2008-03-19 | 默克公司 | Hiv整合酶抑制剂 |
| BRPI0518741A2 (pt) * | 2004-12-03 | 2008-12-02 | Merck & Co Inc | uso de uma combinaÇço de uma droga diretamente metabolizada por ugt1a1 ou um seu sal farmaceuticamente aceitÁvel e atazanavir ou um seu sal farmaceuticamente aceitÁvel, e, combinaÇço farmacÊutica para administraÇço oral a um mamÍfero |
| AU2005311714B2 (en) * | 2004-12-03 | 2010-09-30 | Merck Sharp & Dohme Corp. | Pharmaceutical composition containing an anti-nucleating agent |
| UA87884C2 (uk) * | 2004-12-03 | 2009-08-25 | Мерк Энд Ко., Инк. | Безводна кристалічна калієва сіль інгібітора віл-інтегрази |
| WO2006060711A2 (en) | 2004-12-03 | 2006-06-08 | Merck & Co., Inc. | Pharmaceutical formulation of carboxamide hiv integrase inhibitors containing a release rate controlling composition |
| JP5116660B2 (ja) * | 2005-03-31 | 2013-01-09 | イステイチユート・デイ・リチエルケ・デイ・ビオロジア・モレコラーレ・ピ・アンジエレツテイ・エツセ・エルレ・エルレ | Ｈｉｖインテグラーゼ阻害剤 |
| PL3372281T3 (pl) | 2005-04-28 | 2021-12-27 | Viiv Healthcare Company | Policykliczne pochodne karbamoilopirydonu o aktywności inhibitorowej wobec integrazy HIV |
| EP1881825B1 (en) * | 2005-05-10 | 2013-07-24 | Merck Sharp & Dohme Corp. | Hiv integrase inhibitors |
| EP1906971A2 (en) * | 2005-07-27 | 2008-04-09 | Gilead Sciences, Inc. | Antiviral compounds |
| US7939537B2 (en) * | 2005-10-04 | 2011-05-10 | Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. | HIV integrase inhibitors |
| AU2006306355A1 (en) * | 2005-10-27 | 2007-05-03 | Merck & Co., Inc. | HIV integrase inhibitors |
| US20070129379A1 (en) * | 2005-12-01 | 2007-06-07 | Bristol-Myers Squibb Company | Hiv integrase inhibitors |
| US20090136570A1 (en) * | 2006-01-20 | 2009-05-28 | Bhagwant Rege | Taste-Masked Tablets and Granules |
| WO2008010964A1 (en) * | 2006-07-17 | 2008-01-24 | Merck & Co., Inc. | 1-hydroxy naphthyridine compounds as anti-hiv agents |
| MX2009000661A (es) | 2006-07-19 | 2009-03-27 | Univ Georgia Res Found | Piridinon-diceto-acidos: inhibidores de replicacion de vih en terapia de combinacion. |
| EP2084160A1 (en) * | 2006-10-18 | 2009-08-05 | Merck & Co., Inc. | Hiv integrase inhibitors |
| CN101206209B (zh) * | 2006-12-19 | 2011-08-10 | 北京德众万全药物技术开发有限公司 | 一种用hplc法分析西多福韦原料及其制剂的方法 |
| US7763630B2 (en) | 2007-06-06 | 2010-07-27 | Bristol-Myers Squibb Company | HIV integrase inhibitors |
| DE602008005316D1 (de) * | 2007-06-22 | 2011-04-14 | Bristol Myers Squibb Co | Tablettierte atazanavirhaltige zusammensetzungen |
| CA2702317A1 (en) * | 2007-07-09 | 2009-01-15 | Concert Pharmaceuticals, Inc. | Novel pyrimidinecarboxamide derivatives |
| EP2234608A2 (en) | 2007-12-11 | 2010-10-06 | Viamet Pharmaceuticals, Inc. | Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties |
| BRPI0821349A2 (pt) | 2007-12-21 | 2019-09-24 | Hoffmann La Roche | compostos antivirais heterocíclicos |
| JP5564435B2 (ja) * | 2008-01-08 | 2014-07-30 | メルク・シャープ・アンド・ドーム・コーポレーション | Ｎ−置換ヒドロキシピリミジノンカルボキサミドの製造方法 |
| WO2010000030A1 (en) * | 2008-07-02 | 2010-01-07 | Avexa Limited | Thiazopyrimidinones and uses thereof |
| WO2010042392A2 (en) * | 2008-10-06 | 2010-04-15 | Merck & Co., Inc. | Hiv integrase inhibitors |
| US8143244B2 (en) * | 2009-02-26 | 2012-03-27 | Bristol-Myers Squibb Company | Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors |
| US8742105B2 (en) | 2009-06-02 | 2014-06-03 | Hetero Research Foundation | Polymorphs of raltegravir potassium |
| MX2011013446A (es) * | 2009-07-06 | 2012-02-13 | Syngenta Participations Ag | Compuetos insecticidas. |
| WO2011024192A2 (en) | 2009-07-27 | 2011-03-03 | Matrix Laboratories Ltd | Novel polymorphs of raltegravir |
| US8383639B2 (en) | 2009-10-15 | 2013-02-26 | Bristol-Myers Squibb Company | HIV integrase inhibitors |
| ES2898348T3 (es) | 2009-10-26 | 2022-03-07 | Merck Sharp & Dohme | Composiciones farmacéuticas sólidas que contienen un inhibidor de la integrasa |
| DE102009056636A1 (de) | 2009-12-02 | 2011-06-09 | Ratiopharm Gmbh | Raltegravir-Polymorphe |
| US8283366B2 (en) | 2010-01-22 | 2012-10-09 | Ambrilia Biopharma, Inc. | Derivatives of pyridoxine for inhibiting HIV integrase |
| PL2542084T3 (pl) * | 2010-03-04 | 2018-05-30 | Merck Sharp & Dohme Corp. | Inhibitory katecholo-O-metylotransferazy i ich zastosowanie w leczeniu zaburzeń psychotycznych |
| CA2789471C (en) | 2010-03-04 | 2018-01-02 | Merck Sharp & Dohme Corp. | Inhibitors of catechol o-methyl transferase and their use in the treatment of psychotic disorders |
| CA2789474A1 (en) | 2010-03-04 | 2011-09-09 | Merck Sharp & Dohme Corp. | Inhibitors of catechol o-methyl transferase and their use in the treatment of psychotic disorders |
| US9260413B2 (en) | 2010-03-04 | 2016-02-16 | Merck Sharp & Dohme Corp. | Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disorders |
| SI2796458T1 (en) * | 2010-04-01 | 2018-04-30 | Teva Pharmaceutical Industries Ltd. | CRYSTALINIC SODIUM RALTEGRAVIR SOLUTIONS |
| WO2011120153A1 (en) * | 2010-04-01 | 2011-10-06 | Critical Outcome Technologies Inc. | Compounds and method for treatment of hiv |
| CN102917695A (zh) | 2010-04-09 | 2013-02-06 | 百时美施贵宝公司 | 具有改进的pH效应的阿扎那韦硫酸盐制剂 |
| WO2011148381A1 (en) | 2010-05-25 | 2011-12-01 | Hetero Research Foundation | Salts of raltegravir |
| US9107922B2 (en) | 2010-07-16 | 2015-08-18 | Concert Pharmaceuticals, Inc. | Pyrimidinecarboxamide derivatives |
| CN101914067B (zh) * | 2010-08-26 | 2012-07-11 | 陈岱岭 | N-甲基嘧啶酮的合成方法 |
| WO2012103105A1 (en) * | 2011-01-24 | 2012-08-02 | Assia Chemical Industries Ltd. | Processes for preparing raltegravir and intermediates in the processes |
| WO2012137142A1 (en) | 2011-04-06 | 2012-10-11 | Lupin Limited | Novel salts of raltegravir |
| US9968607B2 (en) | 2011-04-25 | 2018-05-15 | Hetero Research Foundation | Pharmaceutical compositions of raltegravir, methods of preparation and methods of use therof |
| EP2522665A1 (en) | 2011-05-03 | 2012-11-14 | Sandoz Ag | Crystalline sodium salt of an HIV integrase inhibitor |
| ES2450944T3 (es) | 2011-06-01 | 2014-03-25 | Ratiopharm Gmbh | Composición y comprimido que comprenden raltegravir |
| CN103130788B (zh) * | 2011-11-24 | 2015-09-02 | 南开大学 | 嘧啶酰胺类化合物及其制备方法、抗hiv活性和抗tmv活性 |
| CN103130787B (zh) * | 2011-11-24 | 2015-06-10 | 南开大学 | 嘧啶酮酰胺类化合物及其制备方法、抗hiv活性和抗tmv活性 |
| CA3131037A1 (en) | 2011-11-30 | 2013-06-06 | Emory University | Antiviral jak inhibitors useful in treating or preventing retroviral and other viral infections |
| US9403809B2 (en) * | 2011-12-26 | 2016-08-02 | Emcure Pharmaceuticals Limited | Synthesis of raltegravir |
| EP2806857A1 (en) | 2012-01-25 | 2014-12-03 | Lupin Limited | Stable amorphous raltegravir potassium premix and process for the preparation thereof |
| WO2014014933A1 (en) * | 2012-07-20 | 2014-01-23 | Merck Sharp & Dohme Corp. | Hiv treatment with amido-substituted pyrimidinone derivatives |
| BR112015002516A2 (pt) | 2012-08-06 | 2017-07-04 | European Molecular Biology Laboratory | derivados de ácido carbônico di-hidroxipirimidina e seu uso no tratamento, melhora ou prevenção de doença viral. |
| CN102911124B (zh) * | 2012-10-25 | 2015-11-25 | 山东大学 | 羟基嘧啶酮类化合物及其制备方法与应用 |
| JP2015536940A (ja) | 2012-10-29 | 2015-12-24 | シプラ・リミテッド | 抗ウイルス性ホスホネート類似体及びその製造方法 |
| EP2931730B1 (en) | 2012-12-17 | 2019-08-07 | Merck Sharp & Dohme Corp. | 4-pyridinonetriazine derivatives as hiv integrase inhibitors |
| SI3067358T1 (sl) | 2012-12-21 | 2019-12-31 | Gilead Sciences, Inc. | Policiklične spojine karbamoilpiridona in njihova farmacevtska uporaba |
| US9493479B2 (en) | 2013-04-16 | 2016-11-15 | Merck Sharp & Dohme Corp. | Substituted pyrido[1,2-a]pyrazines as HIV integrase inhibitors |
| SI2997033T1 (en) | 2013-05-17 | 2018-04-30 | Merck Sharp & Dohme Corp. | FUZYCLE TRICYCLE HETEROCYCLIC COMPOUNDS AS HIV INTEGRATED INHIBITORS |
| EP3008044B1 (en) | 2013-06-13 | 2018-11-21 | Merck Sharp & Dohme Corp. | Fused tricyclic heterocyclic compounds as hiv integrase inhibitors |
| AU2014286993B2 (en) | 2013-07-12 | 2018-10-25 | Gilead Sciences, Inc. | Polycyclic-carbamoylpyridone compounds and their use for the treatment of HIV infections |
| NO2865735T3 (enExample) | 2013-07-12 | 2018-07-21 | ||
| HK1221648A1 (zh) | 2013-09-27 | 2017-06-09 | Merck Sharp & Dohme Corp. | 用作hiv整合酶抑制劑的取代喹嗪衍生物 |
| WO2015096651A1 (en) | 2013-12-23 | 2015-07-02 | Merck Sharp & Dohme Corp. | Pyrimidone carboxamide compounds as pde2 inhibitors |
| PT3102565T (pt) | 2014-02-03 | 2019-04-01 | Mylan Laboratories Ltd | Processos para a preparação de intermediários de raltegravir |
| US10391178B2 (en) | 2014-03-21 | 2019-08-27 | Mylan Laboratories Limited | Premix of crystalline raltegravir potassium salt and a process for the preparation thereof |
| TW201613936A (en) | 2014-06-20 | 2016-04-16 | Gilead Sciences Inc | Crystalline forms of(2R,5S,13aR)-8-hydroxy-7,9-dioxo-n-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide |
| TWI744723B (zh) | 2014-06-20 | 2021-11-01 | 美商基利科學股份有限公司 | 多環型胺甲醯基吡啶酮化合物之合成 |
| NO2717902T3 (enExample) | 2014-06-20 | 2018-06-23 | ||
| US9353093B2 (en) | 2014-10-07 | 2016-05-31 | Allergan, Inc. | Indole-1-carboxamides as kinase inhibitors |
| WO2016075605A1 (en) | 2014-11-10 | 2016-05-19 | Aurobindo Pharma Ltd | An improved process for the preparation of raltegravir |
| TWI695003B (zh) | 2014-12-23 | 2020-06-01 | 美商基利科學股份有限公司 | 多環胺甲醯基吡啶酮化合物及其醫藥用途 |
| WO2016145614A1 (en) | 2015-03-17 | 2016-09-22 | Merck Sharp & Dohme Corp. | Triazolyl pyrimidinone compounds as pde2 inhibitors |
| EP3285581B1 (en) | 2015-03-26 | 2021-08-11 | Merck Sharp & Dohme Corp. | Pyrazolyl pyrimidinone compounds as pde2 inhibitors |
| CA2980362C (en) | 2015-04-02 | 2020-02-25 | Gilead Sciences, Inc. | Polycyclic-carbamoylpyridone compounds and their pharmaceutical use |
| WO2016187788A1 (en) | 2015-05-25 | 2016-12-01 | Merck Sharp & Dohme Corp. | Fused tricyclic heterocyclic compounds useful for treating hiv infection |
| EP3313852B1 (en) | 2015-06-25 | 2021-01-20 | Merck Sharp & Dohme Corp. | Substituted pyrazolo/imidazolo bicyclic compounds as pde2 inhibitors |
| WO2017000277A1 (en) | 2015-07-01 | 2017-01-05 | Merck Sharp & Dohme Corp. | Substituted triazolo bicycliccompounds as pde2 inhibitors |
| WO2017087257A1 (en) | 2015-11-17 | 2017-05-26 | Merck Sharp & Dohme Corp. | Amido-substituted pyridotriazine derivatives useful as hiv integrase inhibitors |
| US10544155B2 (en) | 2015-12-15 | 2020-01-28 | Merck Sharp & Dohme Corp. | Spirocyclic quinolizine derivatives useful as HIV integrase inhibitors |
| WO2017113288A1 (en) | 2015-12-31 | 2017-07-06 | Merck Sharp & Dohme Corp. | Fused tricyclic heterocyclic compounds as hiv integrase inhibitors |
| EP3472134B1 (en) | 2016-06-21 | 2021-10-20 | Pharmathen S.A. | Process for preparing compounds useful as intermediates for the preparation of raltegravir |
| WO2018051239A1 (en) | 2016-09-15 | 2018-03-22 | Lupin Limited | Process for the preparation of pure and stable crystalline raltegravir potassium form 3 |
| KR20190086017A (ko) | 2016-12-02 | 2019-07-19 | 머크 샤프 앤드 돔 코포레이션 | Hiv 인테그라제 억제제로서 유용한 트리시클릭 헤테로사이클 화합물 |
| JOP20190130A1 (ar) | 2016-12-02 | 2019-06-02 | Merck Sharp & Dohme | مركبات حلقية غير متجانسة رباعية الحلقات مفيدة كمثبطات إنزيم مدمج لفيروس نقص المناعة البشرية (hiv) |
| US10786488B2 (en) | 2017-01-26 | 2020-09-29 | Merck Sharp & Dohme Corp. | Substituted quinolizine derivatives useful as HIV integrase inhibitors |
| WO2019096773A1 (en) | 2017-11-14 | 2019-05-23 | Cambrex Profarmaco Milano S.R.L. | Process for the preparation of raltegravir |
| AU2019395005B2 (en) | 2018-12-06 | 2025-06-05 | Constellation Pharmaceuticals, Inc. | Modulators of TREX1 |
| AU2020316056A1 (en) * | 2019-07-23 | 2022-02-03 | Constellation Pharmaceuticals, Inc. | Modulators of TREX1 |
| US12465565B2 (en) | 2020-01-23 | 2025-11-11 | Lupin Limited | Pharmaceutical compositions of raltegravir |
| WO2021165927A1 (en) * | 2020-02-21 | 2021-08-26 | Wockhardt Bio Ag | 2-cyanopyrroldines, -piperidines or -dazepines as hyperglycemic agents |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR860712B (en) | 1985-03-16 | 1986-07-16 | Wellcome Found | Antiviral compounds |
| US5047407A (en) | 1989-02-08 | 1991-09-10 | Iaf Biochem International, Inc. | 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties |
| US6642245B1 (en) | 1990-02-01 | 2003-11-04 | Emory University | Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane |
| US5637618A (en) * | 1990-06-01 | 1997-06-10 | Bioresearch, Inc. | Specific eatable taste modifiers |
| DE4029654A1 (de) | 1990-09-19 | 1992-04-02 | Hoechst Ag | 2-phenyl-pyrimidine, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung als fungizide |
| US5665720A (en) | 1992-08-07 | 1997-09-09 | Merck & Co., Inc. | Benzoxazinones as inhibitors of HIV reverse transcriptase |
| TW287160B (enExample) | 1992-12-10 | 1996-10-01 | Hoffmann La Roche | |
| US5919776A (en) * | 1996-12-20 | 1999-07-06 | Merck & Co., Inc. | Substituted aminoquinolines as modulators of chemokine receptor activity |
| US5935946A (en) | 1997-07-25 | 1999-08-10 | Gilead Sciences, Inc. | Nucleotide analog composition and synthesis method |
| US6632823B1 (en) | 1997-12-22 | 2003-10-14 | Merck & Co., Inc. | Substituted pyridine compounds useful as modulators of acetylcholine receptors |
| NZ506435A (en) * | 1998-03-26 | 2002-08-28 | Shionogi & Co | 3-Indoly-2-hydroxy-4-oxo-2-butanoic acid useful as antiviral activity |
| EP1086091A4 (en) | 1998-06-03 | 2001-10-10 | Merck & Co Inc | INTEGRASE HIV INHIBITORS |
| EP1082121A4 (en) | 1998-06-03 | 2003-02-05 | Merck & Co Inc | HIV integrase |
| US6306891B1 (en) * | 1998-06-03 | 2001-10-23 | Merck & Co., Inc. | HIV integrase inhibitors |
| JP3453362B2 (ja) | 1998-08-20 | 2003-10-06 | 富山化学工業株式会社 | 含窒素複素環カルボキサミド誘導体またはその塩並びにそれらを含有する抗ウイルス剤 |
| PL348596A1 (en) * | 1998-12-25 | 2002-06-03 | Shionogi & Co | Aromatic heterocycle compounds having hiv integrase inhibiting activities |
| AU2946300A (en) * | 1999-03-04 | 2000-09-21 | Korea Research Institute Of Chemical Technology | Antiviral 2,4-pyrimidinedione derivatives and process for the preparation thereof |
| CA2370500A1 (en) | 1999-06-25 | 2001-01-04 | Lekhanh O. Tran | 1-(aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof |
| ES2542326T3 (es) | 2000-05-08 | 2015-08-04 | Janssen Pharmaceutica Nv | Inhibidores de la replicación del VIH |
| GB0017676D0 (en) * | 2000-07-19 | 2000-09-06 | Angeletti P Ist Richerche Bio | Inhibitors of viral polymerase |
| NZ525088A (en) * | 2000-10-12 | 2004-11-26 | Merck & Co Inc | Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors |
| WO2002030426A1 (en) | 2000-10-12 | 2002-04-18 | Merck & Co., Inc. | Aza- and polyaza-naphthalenyl-carboxamides useful as hiv integrase inhibitors |
| EP1333831A2 (en) | 2000-10-12 | 2003-08-13 | Merck & Co., Inc. | Aza-and polyaza-naphthalenyl ketones useful as hiv integrase inhibitors |
| JP2004517860A (ja) | 2000-10-12 | 2004-06-17 | メルク エンド カムパニー インコーポレーテッド | Ｈｉｖインテグラーゼ阻害薬として有用なアザ−およびポリアザ−ナフタレニルカルボキサミド類 |
| PL365027A1 (en) * | 2001-03-01 | 2004-12-27 | Shionogi & Co, Ltd. | Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity |
| DK2266958T1 (da) * | 2001-08-10 | 2016-04-04 | Shionogi & Co | Antiviralt middel |
| AU2002334205B2 (en) * | 2001-10-26 | 2007-07-05 | Istituto Di Ricerche Di Biologia Molecolara P. Angeletti Spa | Dihydroxypyrimidine carboxamide inhibitors of HIV integrase |
| SI1441735T1 (sl) * | 2001-10-26 | 2006-06-30 | Angeletti P Ist Richerche Bio | N-substituirani hidroksipirimidinon-karboksamidniinhibitorji HIV-integraze |
| WO2003047564A1 (en) | 2001-12-05 | 2003-06-12 | Shionogi & Co., Ltd. | Derivative having hiv integrase inhibitory activity |
| WO2004004657A2 (en) | 2002-07-09 | 2004-01-15 | Bristol-Myers Squibb Company | Hiv integrase inhibitors |
| BRPI0306214B1 (pt) | 2002-11-20 | 2017-08-08 | Japan Tobacco Inc. | 4-oxoquinoline compound and use of this as a hiv integrase inhibitor |
| US7135467B2 (en) | 2003-01-13 | 2006-11-14 | Bristol-Myers Squibb Company | HIV integrase inhibitors |
| US7037908B2 (en) | 2003-04-24 | 2006-05-02 | Bristol-Myers Squibb Company | HIV integrase inhibitors |
-
2002
- 2002-10-21 SI SI200230296T patent/SI1441735T1/sl unknown
- 2002-10-21 WO PCT/GB2002/004753 patent/WO2003035077A1/en not_active Ceased
- 2002-10-21 CN CN2011100924805A patent/CN102219750B/zh not_active Expired - Lifetime
- 2002-10-21 ME MEP-2008-637A patent/ME00427B/me unknown
- 2002-10-21 DE DE200812000016 patent/DE122008000016I1/de active Pending
- 2002-10-21 UA UA20040503960A patent/UA77454C2/uk unknown
- 2002-10-21 DE DE122009000048C patent/DE122009000048I1/de active Pending
- 2002-10-21 MX MXPA04003932A patent/MXPA04003932A/es active IP Right Grant
- 2002-10-21 HU HU0401740A patent/HU230248B1/hu active Protection Beyond IP Right Term
- 2002-10-21 EP EP02801950A patent/EP1441735B1/en not_active Expired - Lifetime
- 2002-10-21 EA EA200400585A patent/EA007060B1/ru active Protection Beyond IP Right Term
- 2002-10-21 PL PL369223A patent/PL212914B1/pl unknown
- 2002-10-21 IL IL16133702A patent/IL161337A0/xx unknown
- 2002-10-21 AT AT02801950T patent/ATE318140T1/de active
- 2002-10-21 KR KR1020047006234A patent/KR100862879B1/ko not_active Expired - Lifetime
- 2002-10-21 US US10/493,280 patent/US7169780B2/en not_active Expired - Lifetime
- 2002-10-21 CN CN201110092477.3A patent/CN102229605B/zh not_active Expired - Lifetime
- 2002-10-21 BR BRPI0213522A patent/BRPI0213522C1/pt not_active IP Right Cessation
- 2002-10-21 GE GE5592A patent/GEP20063848B/en unknown
- 2002-10-21 CN CN028257650A patent/CN1700918B/zh not_active Expired - Lifetime
- 2002-10-21 CA CA002463976A patent/CA2463976C/en not_active Expired - Lifetime
- 2002-10-21 JP JP2003537644A patent/JP3927175B2/ja not_active Expired - Lifetime
- 2002-10-21 ES ES02801950T patent/ES2258668T3/es not_active Expired - Lifetime
- 2002-10-21 DK DK02801950T patent/DK1441735T3/da active
- 2002-10-21 PT PT02801950T patent/PT1441735E/pt unknown
- 2002-10-21 RS YUP-356/04A patent/RS51542B/sr unknown
- 2002-10-21 NZ NZ533057A patent/NZ533057A/en not_active IP Right Cessation
- 2002-10-21 HR HRP20040373AA patent/HRP20040373B1/xx not_active IP Right Cessation
- 2002-10-21 DE DE60209381T patent/DE60209381T2/de not_active Expired - Lifetime
-
2004
- 2004-04-07 IS IS7213A patent/IS2436B/is unknown
- 2004-04-09 IL IL161337A patent/IL161337A/en active IP Right Grant
- 2004-04-13 ZA ZA2004/02796A patent/ZA200402796B/en unknown
- 2004-04-21 CO CO04036632A patent/CO5580777A2/es active IP Right Grant
- 2004-05-25 NO NO20042165A patent/NO325206B1/no not_active IP Right Cessation
-
2006
- 2006-07-24 US US11/491,815 patent/US7217713B2/en not_active Expired - Lifetime
- 2006-12-19 US US11/641,508 patent/US7435734B2/en not_active Expired - Lifetime
-
2008
- 2008-03-31 NL NL300340C patent/NL300340I2/nl unknown
- 2008-04-08 LU LU91428C patent/LU91428I2/fr unknown
- 2008-04-11 CY CY200800008C patent/CY2008008I1/el unknown
- 2008-04-18 LT LTPA2008007C patent/LTC1441735I2/lt unknown
- 2008-06-06 NO NO2008007C patent/NO2008007I1/no not_active IP Right Cessation
- 2008-06-17 FR FR08C0026C patent/FR08C0026I2/fr active Active
- 2008-06-20 US US12/214,595 patent/US7820660B2/en not_active Expired - Lifetime
-
2010
- 2010-09-17 US US12/884,734 patent/US20110034449A1/en not_active Abandoned
-
2016
- 2016-04-07 HU HUS1600016C patent/HUS1600016I1/hu unknown
-
2020
- 2020-08-10 NO NO2020026C patent/NO2020026I1/no not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005511543A5 (enExample) | ||
| ME00427B (me) | N-supstituisani hidroksipiramidinon karboksamidni inhibitori hiv integraze | |
| JP2005510500A5 (enExample) | ||
| RU2361860C2 (ru) | Новые замещенные 3-сера-индолы | |
| JP2007519754A5 (enExample) | ||
| JP2020502229A5 (enExample) | ||
| RU2009125620A (ru) | Органические соединения | |
| RU2439068C2 (ru) | Модуляторы mglur5 | |
| JP2014511869A5 (enExample) | ||
| RU2010110640A (ru) | Соединения и композиции 5-(4-(галогеналкокси)фенил)пиримидин-2-амина в качестве ингибиторов киназ | |
| JP2001526223A5 (enExample) | ||
| RU2018104868A (ru) | 2-амино-3-фтор-3-(фторметил)-6-метил-6-фенил-3,4,5,6-тетрагидропиридины в качестве ингибиторов bace1 | |
| JP2010508338A5 (enExample) | ||
| JP2009506039A5 (enExample) | ||
| JP2013503901A5 (enExample) | ||
| RU2013133800A (ru) | Селективные к bcl-2 агенты, вызывающие апоптоз, для лечения рака и иммунных заболеваний | |
| JP2018527336A5 (enExample) | ||
| RU2012112151A (ru) | Соединения как модуляторы тирозинкиназы | |
| RU2008141509A (ru) | Mglur5 модуляторы 1 | |
| JP2010505832A5 (enExample) | ||
| JP2006500348A5 (enExample) | ||
| HRP20211255T1 (hr) | Derivati pirana kao inhibitori cyp11a1 (citokrom p450 monooksigenaze 11a1) | |
| RU2009149216A (ru) | Бициклические амиды как ингибиторы киназы | |
| JP2019518036A5 (enExample) | ||
| JP2013517283A5 (enExample) |